NPR’s Marketplace features PAL Director discussing GSK’s alli
NPR’s Marketplace morning featured two stories today on the launch of GSK’s over-the-counter weight loss drug alli. One of these stories featured Prescription Access Litigation director Alex Sugerman-Brozan discussing alli and why it should not be available over-the-counter. A streaming version of the story can be found here.















June 15th, 2007 at 5:31 AM
Nice post! You have said it very well. Keep going.
June 15th, 2007 at 6:18 PM
http://alliconnect.wordpress.com/
Its seems alli has a lot of side effects…
possibly colon cancer and a lot of number twos…